Timing Big Decisions When Emotions Run High (Ep. 33)
A major career opportunity can look right on paper and still create difficult questions about family, identity, risk, and what comes next.
How do you make a thoughtful decision when the stakes feel personal?
In this episode, Danton Troyer and Kyle Luetters speak with Rob Stachlewitz, CEO of Resolian, about making major career decisions under pressure. Rob shares how family, longtime mentors, financial planning, and careful reflection helped him evaluate becoming a CEO. He also explores leadership, career identity, finding purpose beyond traditional retirement, and why slowing down can help when an opportunity could reshape both work and family life.
Rob discusses:
- How family, mentors, and financial planning helped him evaluate a major late-career opportunity
- Why trusted mentors can reveal risks and possibilities that are difficult to recognize on your own
- How a player-coach leadership style shapes the way he approaches his responsibilities as a CEO
- Why career identity and purpose can make the transition toward retirement more difficult to define
- How slowing down during high-pressure decisions can create room for family priorities and clear thinking
- And more!
Connect With Danton Troyer:
- Moneta Group
- LinkedIn: Danton Troyer
- dtroyer@monetagroup.com
- (314) 735-9087
Connect With Kyle Luetters:
- Moneta Group
- LinkedIn: Kyle Luetters
- kluetters@monetagroup.com
- (314) 536-8297
Connect With Rob Stachlewitz:
About Our Guest:
Rob has over 25 years of pharmaceutical development and laboratory operations management experience. He has led large, multinational operations groups supporting analytical services and large sites supporting nonclinical toxicology and analytical services. Rob has seen the contract laboratory business from both sides as an outsourcing manager for a large pharmaceutical client and a senior executive in a contract research organization. His pharmaceutical development experience includes roles within Abbott Laboratories and Boehringer Ingelheim. Prior to joining Resolian, Rob was a Vice President in Safety Assessment for Charles River. He is passionate about getting new medicines to the patients who need them.
Rob earned his B.S. Degree in Biology and Teaching from Michigan State University and his Ph.D. In Pharmacology from the University of North Carolina at Chapel Hill. Rob is also a Diplomate of the American Board of Toxicology.
Podcast: Play in new window | Download | Embed